0 Yorum
0 Paylar
105 Görüntüleme
Arama
Yeni insanlar keşfedin, yeni bağlantılar kurun ve yeni arkadaşlar edinin
-
Haber Akışı
- KEŞFEDIN
-
Sayfalar
-
Gruplar
-
Etkinlikler
-
Bloglar
-
Beğenmek, paylaşmak ve yorum yapmak için lütfen giriş yapın!
-
Asia Pacific Biologics Contract Manufacturing Market Poised for Strong Growth as Vaccine Manufacturing, Biosimilars, and Digital Technologies Accelerate DemandThe Asia Pacific biologics contract manufacturing market is entering a high-growth phase, supported by rising biopharmaceutical demand, expanding biologics pipelines, and increasing outsourcing among small and virtual biotechnology companies. According to Transparency Market Research, the market is projected to reach US$9.8 billion by 2031, expanding at a 14.5% CAGR from 2021 to 2031. Growing...0 Yorum 0 Paylar 182 Görüntüleme
-
Biosimilars Manufacturing Market: Industry Size, Share, Biopharmaceutical Production Trends, and Forecast by 2033" According to the latest report published by Data Bridge Market Research, the Biosimilars Manufacturing Market CAGR Value As per Data Bridge Market Research Analysis The biosimilars manufacturing market was valued at USD 8.43 billion in 2025 and is projected to reach USD 16.3 billion by 2033, growing at a CAGR of 8.60% from 2026 to 2033 during the...0 Yorum 0 Paylar 140 Görüntüleme
-
Biosimilars Market Outlook 2026–2036: Trends, Segments, and ForecastBiosimilars Market to Reach USD 73.24 Billion by 2036: What Is Driving Growth Healthcare systems around the world are under pressure to deliver advanced therapies at lower cost. Biologic medicines treat cancer, autoimmune disorders, and eye diseases, but their high prices strain budgets. This is where the Biosimilars Market is making a real difference. By offering highly similar alternatives...0 Yorum 0 Paylar 248 Görüntüleme
-
Biosimilars Market Technology Trends Reshaping Biologic Drug Development 2028The Biosimilars Market is benefiting from the expiration of exclusivity periods for major biologic medicines. This is encouraging pharmaceutical manufacturers to develop biosimilar versions of established therapies and compete in previously protected therapeutic segments. The Biosimilars Market size is expected to grow from US$ 18,435.89 million in 2021 to US$ 136,069.53 million by 2028,...0 Yorum 0 Paylar 101 Görüntüleme
-
Biosimilars Market Trends: Why Patent Expirations Are Creating New Opportunities for Biosimilar DrugsBiosimilars Market: Interchangeability, Patent Expiry and the Checkpoint Inhibitor Pipeline The Biosimilars Market comprises biological medicines shown to be highly similar to an already approved reference biologic, with no clinically meaningful differences in safety, purity or potency. In the US, they are approved through the abbreviated 351(k) pathway established under the Biologics Price...0 Yorum 0 Paylar 71 Görüntüleme
-
Herceptin Biosimilars Market Business Shares and Outlook 2030"Executive Summary Herceptin Biosimilars Market Size and Share Analysis Report CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. Herceptin Biosimilars Market report objective analysis is employed to make...0 Yorum 0 Paylar 673 Görüntüleme
-
Herceptin Biosimilars Market Size, Share, Trends, Industry Analysis and Forecast to 2030"Herceptin Biosimilars Market Summary: According to the latest report published by Data Bridge Market Research, the Herceptin Biosimilars Market CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. ...0 Yorum 0 Paylar 485 Görüntüleme
-
Herceptin Biosimilars Market Size, Share, Trends, Industry Growth and Forecast by 2033"Executive Summary Herceptin Biosimilars Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. To better structure this Herceptin Biosimilars report, a nice blend of...0 Yorum 0 Paylar 619 Görüntüleme
-
Herceptin Biosimilars Market: Industry Size, Share, Oncology Biologics & Breast Cancer Therapeutics Trends, and Forecast by 2030" According to the latest report published by Data Bridge Market Research, the Herceptin Biosimilars Market CAGR Value Data Bridge Market Research analyses that the market which was USD 1,810 million in 2022, would rocket up to USD 11,302 million by 2030 and is expected to undergo a CAGR of 23.2% during the forecast period. All the data and information included in the...0 Yorum 0 Paylar 91 Görüntüleme
-
Biopharma Contract Manufacturing Demand Expands With Complex Drug PipelinesThe Biopharmaceuticals Contract Manufacturing Market is expanding as pharmaceutical and biotechnology companies increasingly outsource complex biologics manufacturing to specialized contract development and manufacturing organizations. The market was valued at USD 44.7 billion in 2025 and is projected to grow from USD 50.0 billion in 2026 to USD 100.8 billion by 2033, registering a CAGR of...0 Yorum 0 Paylar 214 Görüntüleme
-
Oncology Biosimilars Market Growth Analysis by Product, Application and Region"Oncology Biosimilars Market Summary According to the latest report published by Data Bridge Market Research, the Oncology Biosimilars Market Global oncology biosimilars market size was valued at USD 6.66 billion in 2024 and is projected to reach USD 25.88 billion by 2032, with a CAGR of 18.5% during the forecast period of 2025 to 2032. An influential Oncology Biosimilars...0 Yorum 0 Paylar 303 Görüntüleme
-
Oncology Immunotherapy Biosimilars Market Analysis: Top Trends Defining Future Industry Success" According to the latest report published by Data Bridge Market Research, the Oncology Immunotherapy Biosimilars Market The global Oncology Immunotherapy Biosimilars market size was valued at USD 891 Million in 2025 and is expected to reach USD 1828.16 Million by 2033, at a CAGR of 9.40% during the forecast period. Oncology Immunotherapy Biosimilars Market report has been...0 Yorum 0 Paylar 345 Görüntüleme
Diğer Sonuçlar
Sponsor
